Virtus ETF Advisers’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-11,762
| Closed | -$100K | – | 410 |
|
|
2021
Q3 | $100K | Sell |
11,762
-617
| -5% | -$5.25K | 0.04% | 382 |
|
|
2021
Q2 | $203K | Buy |
12,379
+1,696
| +16% | +$27.8K | 0.08% | 337 |
|
|
2021
Q1 | $236K | Buy |
10,683
+192
| +2% | +$4.24K | 0.1% | 302 |
|
|
2020
Q4 | $324K | Buy |
+10,491
| New | +$324K | 0.13% | 191 |
|